Related Experiment Video
Updated: Jul 19, 2026

Measuring Volatile and Non-volatile Antifungal Activity of Biocontrol Products
Published on: December 5, 2020
In vitro methods for antifungal susceptibility testing of Trichophyton spp
Maria Elisabete da Silva Barros1, Daniel de Assis Santos, Júnia Soares Hamdan
1Department of Microbiology, Institute of Biological Sciences, Federal University of Minas Gerais, Av. Antônio Carlos, 6627 PO Box 486 CEP: 31.270-901, Belo Horizonte, Minas Gerais, Brazil. betebarros@ef.ufop.br
Abstract:
In general, methods to test the susceptibility of fungi to antifungal drugs require standardized techniques, but so far there is no methodology that is widely applicable to dermatophytes. Here we introduced modifications to the protocols from documents of the National Committee for Clinical Laboratory Standards (CLSI) M38-A and the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (EUCAST) that are usually applied to moulds and fermentative yeasts, in order to adjust the conditions for the growth of dermatophytes. The modifications included: growth on potato dextrose agar supplemented with 2% in-house rice flour to encourage sporulation, the addition of 2% glucose to the culture media (RPMI-1640), and an incubation temperature of 28 degrees C. In addition, the incubation period was 7d, the minimum inhibitory concentration (MIC) was defined as 80% growth inhibition endpoints for azole agents, and the inocula only contained microconidia. Results obtained by both tested methodologies were very similar to the ones reported by other researchers. MIC90 (MIC at which 90% of isolates tested were inhibited) values were identical for four out of five antifungal drugs tested and there was only a difference of one or two dilutions when MIC50 values were compared. Although the modifications introduced did not interfere with the results, more studies are necessary to establish a standard technique to test susceptibility of dermatophytes to antifungal drugs.
Insights
Standardized antifungal susceptibility testing for dermatophytes is lacking. Modified CLSI and EUCAST methods using specific media, temperature, and incubation periods show promising, reproducible results for dermatophyte drug resistance.
Area of Science:
- Mycology
- Antimicrobial Resistance
- Clinical Laboratory Science
Background:
- Standardized methods for antifungal susceptibility testing are crucial but lacking for dermatophytes.
- Existing protocols (CLSI M38-A, EUCAST) are designed for moulds and yeasts, not optimally suited for dermatophyte growth characteristics.
Purpose of the Study:
- To adapt and evaluate modified CLSI and EUCAST protocols for reliable antifungal susceptibility testing of dermatophytes.
- To establish optimized conditions for dermatophyte growth and sporulation to improve testing accuracy.
Main Methods:
- Modified potato dextrose agar with rice flour and RPMI-1640 with glucose were used.
- Incubation at 28°C for 7 days with microconidia inocula and 80% growth inhibition for MIC determination were employed.
Main Results:
- Modified protocols yielded highly reproducible results comparable to existing research.
- MIC90 values were identical for four of five antifungal drugs tested; MIC50 values showed minimal variation (one to two dilutions).
Conclusions:
- The introduced modifications provide a reliable basis for dermatophyte antifungal susceptibility testing.
- Further studies are needed to establish a universally accepted standard technique for dermatophyte antifungal drug susceptibility.
More Related Videos
08:54Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
Published on: February 14, 2018
07:19A 96 Well Microtiter Plate-based Method for Monitoring Formation and Antifungal Susceptibility Testing of Candida albicans Biofilms
Published on: October 21, 2010